RU2497515C2 - Состав для топического применения, содержащий микросферы адапалена и клиндамицин - Google Patents

Состав для топического применения, содержащий микросферы адапалена и клиндамицин Download PDF

Info

Publication number
RU2497515C2
RU2497515C2 RU2010138947/15A RU2010138947A RU2497515C2 RU 2497515 C2 RU2497515 C2 RU 2497515C2 RU 2010138947/15 A RU2010138947/15 A RU 2010138947/15A RU 2010138947 A RU2010138947 A RU 2010138947A RU 2497515 C2 RU2497515 C2 RU 2497515C2
Authority
RU
Russia
Prior art keywords
clindamycin
composition
adapalene
microspheres
acne
Prior art date
Application number
RU2010138947/15A
Other languages
English (en)
Russian (ru)
Other versions
RU2010138947A (ru
Inventor
Ульхас Рамешчандра ДХУППАД
Нитин Бабулал БХАМРЕ
Сунил Судхакар ЧАУДХАРИ
Гириш Рамакришна ТРИВЕДИ
Акхилеш Даянанд ШАРМА
Прашант ДОНГРЕ
Original Assignee
Гленмарк Фармасьютикалс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гленмарк Фармасьютикалс Лимитед filed Critical Гленмарк Фармасьютикалс Лимитед
Publication of RU2010138947A publication Critical patent/RU2010138947A/ru
Application granted granted Critical
Publication of RU2497515C2 publication Critical patent/RU2497515C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
RU2010138947/15A 2008-03-17 2009-03-13 Состав для топического применения, содержащий микросферы адапалена и клиндамицин RU2497515C2 (ru)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
IN532/MUM/2008 2008-03-17
IN532MU2008 2008-03-17
US4214208P 2008-04-03 2008-04-03
US61/042,142 2008-04-03
IN2570/MUM/2008 2008-12-10
IN2570MU2008 2008-12-10
US14117508P 2008-12-29 2008-12-29
US61/141,175 2008-12-29
PCT/IN2009/000173 WO2009116086A2 (en) 2008-03-17 2009-03-13 Stable fixed dose topical formulation

Publications (2)

Publication Number Publication Date
RU2010138947A RU2010138947A (ru) 2012-04-27
RU2497515C2 true RU2497515C2 (ru) 2013-11-10

Family

ID=54199451

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2010138947/15A RU2497515C2 (ru) 2008-03-17 2009-03-13 Состав для топического применения, содержащий микросферы адапалена и клиндамицин

Country Status (9)

Country Link
US (1) US8673356B2 (enExample)
EP (1) EP2265268A4 (enExample)
BR (1) BRPI0908518A2 (enExample)
CA (1) CA2717899A1 (enExample)
IN (1) IN266834B (enExample)
MX (1) MX2010010111A (enExample)
RU (1) RU2497515C2 (enExample)
WO (1) WO2009116086A2 (enExample)
ZA (1) ZA201006849B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2265268A4 (en) 2008-03-17 2011-07-13 Glenmark Pharmaceuticals Ltd STABLE TOPICAL FORMULATION WITH FIXED DOSE
WO2012053014A2 (en) * 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
WO2012053013A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Pharmaceutical compositions of anti-acne agents
WO2012053010A2 (en) 2010-10-21 2012-04-26 Cadila Healthcare Limited Method for treatment of acne using pharmaceutical compositions of clindamycin
WO2013019974A1 (en) * 2011-08-02 2013-02-07 Medicis Pharmaceutical Corporation Compositions comprising a retinoid and a lincosamide antibiotic for use in treating rosacea
CN110279887B (zh) * 2019-07-18 2021-12-14 王月玲 一种多用途光子冷凝胶及其制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2313338C2 (ru) * 2001-12-20 2007-12-27 Дженерал Топикс С.Р.Л. Композиция на основе этиллинолеата и триэтилцитрата для лечения себореи и угрей

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955109A (en) 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
US6462064B1 (en) * 1996-07-08 2002-10-08 Galderma Research & Development S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
US6387383B1 (en) * 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
KR20070091613A (ko) 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
EP2265268A4 (en) 2008-03-17 2011-07-13 Glenmark Pharmaceuticals Ltd STABLE TOPICAL FORMULATION WITH FIXED DOSE

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2313338C2 (ru) * 2001-12-20 2007-12-27 Дженерал Топикс С.Р.Л. Композиция на основе этиллинолеата и триэтилцитрата для лечения себореи и угрей

Also Published As

Publication number Publication date
CA2717899A1 (en) 2009-09-24
US20100068284A1 (en) 2010-03-18
WO2009116086A3 (en) 2009-12-10
EP2265268A4 (en) 2011-07-13
WO2009116086A2 (en) 2009-09-24
MX2010010111A (es) 2010-12-15
IN266834B (enExample) 2015-06-05
EP2265268A2 (en) 2010-12-29
US8673356B2 (en) 2014-03-18
RU2010138947A (ru) 2012-04-27
BRPI0908518A2 (pt) 2015-09-29
ZA201006849B (en) 2011-06-29

Similar Documents

Publication Publication Date Title
RU2404759C2 (ru) Фармацевтические композиции местного применения, содержащие противоугревое соединение и антибиотическое соединение
US10821075B1 (en) Compositions for topical application of a medicaments onto a mammalian body surface
CN103142460B (zh) 含有至少一种萘甲酸衍生物、过氧化苯甲酰和至少一种成膜剂的组合物、它们的制备方法及其用途
US8008345B2 (en) Dermal therapy using phosphate derivatives of electron transfer agents
RU2459612C2 (ru) Композиции, содержащие пероксид бензоила,по меньшей мере одно производное нафтойной кислоты и по меньшей мере одно соединение типа полиуретановых полимеров или их производных, и их применение
US10702604B2 (en) Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing the same, process for preparing the same and use thereof in dermatology
US20090191245A1 (en) Reduced-irritant dermatological compositions comprising at least one naphthoic acid compound and benzoyl peroxide and treatment of keratinization disorders therewith
US8709392B2 (en) Cosmetic/dermatological compositions comprising naphthoic acid compounds and polyurethane polymers
EP1051193A1 (en) Anhydrous topical skin preparations
RU2497515C2 (ru) Состав для топического применения, содержащий микросферы адапалена и клиндамицин
JP2012184258A (ja) 少なくとも１つのナフトエ酸誘導体および少なくとも１つのポリウレタンポリマータイプの化合物またはその誘導体を含む組成物、その調製方法、およびその使用
JP2005239705A (ja) 局所的抗菌性製剤
US20140010884A1 (en) Dermatological compositions comprising retinoids, dispersed benzoyl peroxide and carrageenans
US20170020896A1 (en) Topical nanodrug formulation
WO2012053014A2 (en) Method for treatment of acne using pharmaceutical compositions of clindamycin and adapalene
WO2020170034A1 (en) Method for long-term treatment of rosacea
WO2017109761A1 (en) Topical composition for the treatment of acne
US20210290603A1 (en) Methods for treating acne
WO2024144676A1 (en) Hydrogel and organogel formulations containing propolis and dexpanthenol nanoemulsions

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20180314